Hospitalization Outcomes of Acute Pancreatitis in Hematopoietic Stem Cell Transplant Recipients

被引:4
作者
Chaudhry, Hunza [1 ,8 ]
Dhaliwal, Armaan [2 ]
Bains, Kanwal [2 ]
Sohal, Aalam [3 ]
Singla, Piyush [4 ]
Sharma, Raghav [5 ]
Dukovic, Dino [6 ]
Kohli, Isha
Gupta, Gagan [4 ]
Prajapati, Devang [7 ]
机构
[1] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA USA
[2] Univ Arizona, Dept Internal Med, South Campus, Tucson, AZ USA
[3] Liver Inst Northwest, Seattle, WA USA
[4] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India
[5] Punjab Inst Med Sci, Jalandhar, Punjab, India
[6] Ross Univ, Sch Med, Bridgetown, Barbados
[7] Univ Calif San Francisco, Dept Gastroenterol & Hepatol, Fresno, CA USA
[8] Univ Calif San Francisco, Dept Internal Med, Fresno, CA 93722 USA
关键词
Acute pancreatitis; Hematopoietic stem cell transplanta-tion; Hospitalization outcomes; BONE-MARROW TRANSPLANT; RISK-FACTORS; GALLBLADDER; PREVALENCE;
D O I
10.14740/gr1579
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Acute pancreatitis (AP) carries a significant morbid-ity and mortality worldwide. AP is a potential complication of he-matopoietic stem cell transplantation (HSCT) although its incidence remains unclear. HSCT recipients are at increased risk of AP due to various factors but the effect of AP on mortality and resource utiliza-tion in the adult population has not been studied. We investigated the impact of AP on hospitalization outcomes among patients following HSCT.Methods: We queried the National Inpatient Sample (NIS) database using the International Classification of Diseases (ICD)-10 codes. All adult patients with a diagnosis or procedure code of HSCT were included in the study. Patients were divided into those with a diagno-sis of AP and those without. Sensitivity analysis was performed for patients with a length of stay greater than 28 days. The relationship between AP and mortality, length of stay, total hospitalization cost, and charges was assessed using univariate analysis followed by mul-tivariate analysis.Results: Of the 140,130 adult patients with HSCT, 855 (0.61%) pa-tients developed AP. There was 1.74 times higher risk of mortality in patients with AP as compared to controls (adjusted odds ratio (aOR): 1.74, P = 0.0055). There was no statistically significant difference in the length of stay, hospitalization charge, or cost before sensitiv-ity analysis. After sensitivity analysis, 13,240 patients were included, from which 125 (0.94%) had AP. There was 3.85 times higher risk of mortality in patients who developed AP as compared to controls (aOR: 3.85, P = 0.003). There was a statistically significant increase noted in the length of stay (adj coeff: 20.3 days, P = 0.002), hospital charges (+$346,616, P = 0.017), and cost (+$121,932.4, P = 0.001) in patients with AP as compared to those who did not develop AP. Conclusion: Recipients of HSCT who develop AP have shown to have higher mortality on sensitivity analysis. This study highlights that AP in HSCT patients is associated with worse outcomes and higher resource utilization. Physicians should be aware of this asso-ciation as the presence of pancreatitis portends a poor prognosis.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 19 条
[1]  
[Anonymous], 2012, Healthcare Cost and Utilization Project HCUP
[2]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[3]   Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease [J].
Chung, Lo Woei ;
Yeh, Su-Peng ;
Hsieh, Ching-Yun ;
Liao, Yu-Min ;
Huang, Hsin-Hui ;
Lin, Chen-Yuan ;
Chiu, Chang-Fang .
ANNALS OF HEMATOLOGY, 2008, 87 (05) :421-423
[4]  
FRICK MP, 1984, AM J GASTROENTEROL, V79, P122
[5]  
Gapp J, 2019, PANCREAS, V48, P548, DOI [10.1097/MPA.0000000000001275, 10.1097/mpa.0000000000001275]
[6]   Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma [J].
Graf, Solomon A. ;
Vaughn, Jennifer E. ;
Chauncey, Thomas R. ;
Storer, Barry E. ;
Gopal, Ajay K. ;
Holmberg, Leona A. ;
McCune, Jeannine S. ;
Bensinger, William I. ;
Maloney, David G. ;
Press, Oliver W. ;
Storb, Rainer ;
Sorror, Mohamed L. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) :1582-1587
[7]   Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis [J].
Kagoya, Yuki ;
Seo, Sachiko ;
Nannya, Yasuhito ;
Kurokawa, Mineo .
CLINICAL TRANSPLANTATION, 2012, 26 (02) :E168-E175
[8]   Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis [J].
Ko, CW ;
Gooley, T ;
Schoch, HG ;
Myerson, D ;
Hackman, RC ;
Shulman, HM ;
Sale, GE ;
Lee, SP ;
McDonald, GB .
BONE MARROW TRANSPLANTATION, 1997, 20 (12) :1081-1086
[9]  
Maximova Natalia, 2018, Oncotarget, V9, P19543, DOI 10.18632/oncotarget.24646
[10]   DISSEMINATED ADENOVIRAL INFECTION PRESENTING AS ACUTE-PANCREATITIS [J].
NIEMANN, TH ;
TRIGG, ME ;
WINICK, N ;
PENICK, GD .
HUMAN PATHOLOGY, 1993, 24 (10) :1145-1148